Manifold offers an AI platform purpose-built for the $2 trillion life-sciences industry, enabling AI agents to operate on multimodal biomedical data across workflows ranging from target identification and biomarker discovery to clinical trial design and real-world evidence generation. The system includes collaboration infrastructure that lets biopharma companies and medical centers share analyses while maintaining data sovereignty. Manifold serves tens of thousands of users at hundreds of organizations worldwide, with customers such as Foundation Medicine and the University of Virginia and strategic collaborations with the Broad Institute, AWS, and Anthropic. As an operator of the Terra platform, it already supports thousands of researchers globally. The company plans to use new capital to expand its Agent OS, deepen cross-organization collaboration features, and scale its data ecosystem, creating compounding network effects for participants. To date, Manifold has raised $40 million in venture funding, underscoring growing investor confidence in its domain-specific AI approach.

Total raised

$33M

Funding rounds

3

Latest round

Series B

Latest activity

Dec 2025